Search Within

Justin Taylor

  1. "Epidemiology and Biostatistics"
Formats
  1. Journal Article (6)
  2. Meeting Abstract (5)
  3. Research Letter (2)
Groups
  1. Adult Leukemia (13)
  2. Center for Hematologic Malignancies (13)
  3. Department of Medicine (13)
  4. Epidemiology and Biostatistics (13)
  5. Hematologic Malignancies, Division of (13)
  6. Biostatistics Service (12)

More Groups

People
  1. Christopher Famulare (10)
  2. Martin Tallman (10)
  3. Sean Devlin (9)
  4. Aaron Goldberg (8)
  5. Aaron Viny (8)
  6. Andrew Dunbar (8)

More People

Years
  1. 2023 (1)
  2. 2021 (1)
  3. 2020 (2)
  4. 2019 (6)
  5. 2018 (3)
Publications
  1. Blood (5)
  2. American Journal of Hematology (2)
  3. Haematologica (1)
  4. Journal of Hematology & Oncology (1)
  5. Leukemia (1)
  6. Nature (1)

More Publications

Publishers
  1. American Society of Hematology (5)
  2. John Wiley & Sons, Inc. (2)
  3. Nature Publishing Group (2)
  4. American Association for the Advancement of Science (1)
  5. Biomed Central Ltd (1)
  6. Elsevier Science, Inc. (1)

More Publishers

Results (13)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Molecular predictors of immunophenotypic measurable residual disease clearance in acute myeloid leukemia
    Journal Article

    Stahl, M.; Derkach, A.; Farnoud, N.; Bewersdorf, J. P.; Robinson, T.; Famulare, C.; Cho, C.; Devlin, S.; Menghrajani, K.; Patel, M. A.; more...
    American Journal of Hematology (2023)

    Fulltext@MSK | Save
  • The prognosis and durable clearance of RAS mutations in patients with acute myeloid leukemia receiving induction chemotherapy
    Research Letter

    Ball, B. J.; Hsu, M.; Devlin, S. M.; Arcila, M.; Roshal, M.; Zhang, Y.; Famulare, C. A.; Goldberg, A. D.; Cai, S. F.; Dunbar, A.; more...
    American Journal of Hematology (2021)

    Fulltext@MSK | Save
  • Molecular predictors and effectiveness of measurable residual disease (MRD) eradication with chemotherapy and allogeneic stem cell transplantation for acute myeloid leukemia
    Meeting Abstract

    Stahl, M.; Derkach, A.; Famulare, C.; Cho, C.; Devlin, S.; Farnoud, N.; Menghrajani, K.; Patel, M. A.; Cai, S. F.; Geyer, M. B.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Safety and activity of selinexor in patients with myelodysplastic syndromes or oligoblastic acute myeloid leukaemia refractory to hypomethylating agents: A single-centre, single-arm, phase 2 trial
    Journal Article

    Taylor, J.; Mi, X.; Penson, A. V.; Paffenholz, S. V.; Alvarez, K.; Sigler, A.; Chung, S. S.; Rampal, R. K.; Park, J. H.; Stein, E. M.; more...
    The Lancet Haematology (2020)

    Fulltext@MSK | Save
  • RAS mutations are independently associated with decreased overall survival and event-free survival in patients with AML receiving induction chemotherapy
    Meeting Abstract

    Ball, B. J.; Hsu, M.; Devlin, S. M.; Famulare, C.; Cai, S. F.; Dunbar, A.; Epstein-Peterson, Z. D.; Menghrajani, K.; Glass, J. L.; Taylor, J.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • RAS mutations are independently associated with decreased overall survival and event-free survival in patients with AML receiving induction chemotherapy
    Meeting Abstract

    Ball, B. J.; Hsu, M.; Devlin, S. M.; Famulare, C.; Cai, S. F.; Dunbar, A.; Epstein-Peterson, Z. D.; Menghrajani, K.; Glass, J. L.; Taylor, J.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Muscarinic acetylcholine receptor regulates self-renewal of early erythroid progenitors
    Journal Article

    Trivedi, G.; Inoue, D.; Chen, C.; Bitner, L.; Chung, Y. R.; Taylor, J.; Gönen, M.; Wess, J.; Abdel-Wahab, O.; Zhang, L.
    Science Translational Medicine (2019)

    Fulltext@MSK | Save
  • CD33 splice site genotype was not associated with outcomes of patients receiving the anti-CD33 drug conjugate SGN-CD33A
    Research Letter

    Stanchina, M.; Pastore, A.; Devlin, S.; Famulare, C.; Stein, E.; Taylor, J.
    Journal of Hematology & Oncology (2019)

    Fulltext@MSK | Save
  • Loss of plasmacytoid dendritic cell differentiation is highly predictive for post-induction measurable residual disease and inferior outcomes in acute myeloid leukemia
    Journal Article

    Xiao, W.; Goldberg, A. D.; Famulare, C. A.; Devlin, S. M.; Nguyen, N. T.; Sim, S.; Kabel, C. C.; Patel, M. A.; McGovern, E. M.; Patel, A.; more...
    Haematologica (2019)

    Fulltext@MSK | Save
  • Clonal diversity predicts adverse outcome in chronic lymphocytic leukemia
    Journal Article

    Leeksma, A. C.; Taylor, J.; Wu, B.; Gardner, J. R.; He, J.; Nahas, M.; Gonen, M.; Alemayehu, W. G.; te Raa, D.; Walther, T.; more...
    Leukemia (2019)

    Fulltext@MSK | Save